MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-JH-22-0005555
Natoshine Pharmaceutical Private Limited
Natoshine Pharmaceutical Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹40.93 Lakh
▲ 47% YoY
Net profit · FY 2025
₹45,243
Net margin 1.1%
EBITDA · FY 2025
₹87,697
EBITDA margin 2.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About Natoshine Pharmaceutical Private Limited
Data last updated:
Natoshine Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ranchi, under CIN U24232JH2019PTC013535. Its GSTIN is 20AAGCN7073F1ZO (Jharkhand).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Sudha Kumari Dosad and Nandini Mondal.
Its last annual general meeting (AGM) was held on 27 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 1/12 S/F Flat No C – 2 Kh No 1642/1 773/2 774/2 Arya Nagar, New Delhi, Delhi, India – 110047.
As per the financials filed for FY 2025, the company reported a revenue of ₹40.93 Lakh, a growth of 47% compared to the previous year. For the same year it recorded a net profit of ₹45,243 (net margin 1.1%) and EBITDA of ₹87,697 (EBITDA margin 2.1%).
Natoshine Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JH-22-0005555).
Company details
CIN U24232JH2019PTC013535
Registration Number 013535
Incorporation Date 07 October 2019
ROC Ranchi
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 August 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-JH-22-0005555
Recognitions & Rankings of Natoshine Pharmaceutical
Contact details
Natoshine Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 1/12 S/F Flat No C – 2 Kh No 1642/1 773/2 774/2 Arya Nagar, New Delhi, Delhi, India – 110047
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Natoshine Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Natoshine Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Natoshine Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Natoshine Pharmaceutical Private Limited, buy the company report.
Financials of Natoshine Pharmaceutical Private Limited
FY 2025 filings availableNatoshine Pharmaceutical Private Limited reported revenue of ₹40.93 Lakh (up 47% YoY) for FY 2025.
Revenue · FY 2025
₹40.93 Lakh ▲ 47%
Net profit · FY 2025
₹45,243 margin 1.1%
EBITDA · FY 2025
₹87,697 margin 2.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 47%
EBITDA CAGR growth
1 year
▲ 225%
3 years · compounded
▲ 121%
Revenue rose 47% in the latest year. EBITDA rose 225% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹87,697 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45,243 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Natoshine Pharmaceutical Private Limited, buy the company report.
Board of directors of Natoshine Pharmaceutical Private Limited
Natoshine Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sudha Kumari Dosad | Director | 07 Oct 2019 | 7 Years 0 Months | Current |
| Nandini Mondal | Director | 07 Oct 2019 | 7 Years 0 Months | Current |
| Rani Pandey | Additional Director | 05 Feb 2022 | 4 Years 9 Months | Current |
Peer comparison
Natoshine Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Universal Buildrise Private Limited | ₹40.93 Lakh (FY 2017) | -25.0% | New Delhi, Delhi, India | |||
| Aftab Glass Private Limited | ₹40.93 Lakh (FY 2017) | -69.0% | Mumbai, Maharashtra, India | |||
| Gece Private Limited | ₹40.93 Lakh (FY 2021) | 287.0% | Rohtak, Haryana, India | |||
| Agile Industrial Solutions Private Limited | ₹40.93 Lakh (FY 2025) | 1104.0% | Pune, Maharashtra, India | |||
| Xenial Health Care Private Limited | ₹40.93 Lakh (FY 2020) | 78.0% | Navi Mumbai, Maharashtra, India | |||
| Natoshine Pharmaceutical Private Limitedthis company | ₹40.93 Lakh (FY 2025) | ₹45,243 | 1.1% | 47.0% | New Delhi, Delhi, India | |
| Fourstor Solutions Private Limited | ₹40.92 Lakh (FY 2025) | 107.0% | Bengaluru, Karnataka, India | |||
| Asia Graphinnovations Solution Private Limited | ₹40.9 Lakh (FY 2024) | -13.0% | Noida, Uttar Pradesh, India | |||
| Pranathi Fertilizers Private Limited | ₹40.9 Lakh (FY 2024) | -11.0% | Hosur, Tamil Nadu, India | |||
| Img Resources Private Limited | ₹40.89 Lakh (FY 2025) | -15.0% | Kozhikode, Kerala, India | |||
| Ishtikapuri Foods Private Limited | ₹40.88 Lakh (FY 2022) | 380.0% | Etawah, Uttar Pradesh, India |
To see the full peer comparison of Natoshine Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Natoshine Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Natoshine Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Natoshine Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 20AAGCN7073F1ZO | Jharkhand | Active | 08 Aug 2022 |
To see the full GST registrations and return filing status of Natoshine Pharmaceutical Private Limited, buy the company report.
Recent activity
Natoshine Pharmaceutical Private Limited has 4 board changes on record since 2019: 3 appointments and 1 cessation. The latest: Rani Pandey was appointed as Additional Director on 05 Feb 2022.
AGM
Natoshine Pharmaceutical Private Limited last Annual general meeting of members was held on 27 Aug 2025 as per latest MCA records.
Filing
Natoshine Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ranchi.
Appointed
Rani Pandey was appointed as Additional Director.
Ceased
Rani Pandey ceased to be Director.
Appointed
Nandini Mondal was appointed as Director.
Appointed
Sudha Kumari Dosad was appointed as Director.
Incorporation
07 Oct 2019
Natoshine Pharmaceutical Private Limited was registered on 07 Oct 2019 with Roc Ranchi & aged 7 years 30 days as per MCA records.
Frequently asked questions
Natoshine Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 October 2019 (7+ years old) and is registered under CIN U24232JH2019PTC013535.
Natoshine Pharmaceutical has 3 current directors:
- Sudha Kumari Dosad - Director
- Nandini Mondal - Director
- Rani Pandey - Additional Director
The latest financial statements of Natoshine Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 August 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Natoshine Pharmaceutical is 20AAGCN7073F1ZO, registered in Jharkhand.
The CIN (Corporate Identification Number) of Natoshine Pharmaceutical is U24232JH2019PTC013535. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Natoshine Pharmaceutical was incorporated on 07 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ranchi.
The peers of Natoshine Pharmaceutical by revenue are Universal Buildrise Private Limited, Aftab Glass Private Limited, Gece Private Limited, Agile Industrial Solutions Private Limited, Xenial Health Care Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Rani Pandey was appointed as Additional Director on 05 Feb 2022. Rani Pandey ceased to be Director on 05 Feb 2022. Nandini Mondal was appointed as Director on 07 Oct 2019. Natoshine Pharmaceutical has 4 board changes on record in total.
Yes, Natoshine Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-JH-22-0005555).
The registered office of Natoshine Pharmaceutical is at A – 112 SF Flat No C – 2 Kh No 16421 7732 7742 Arya Nagar, New Delhi, Delhi, India – 110047.
Natoshine Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages